Old Web
English
Sign In
Acemap
>
authorDetail
>
Richa Shah
Richa Shah
Pfizer
Medicine
Engineering management
Management science
Globalization
Best practice
4
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
2021
Journal of Clinical Oncology
Marcos de Lima
Partow Kebriaei
Francesco Lanza
Christina Cho
Sergio Giralt
Gizelle Popradi
Michael T. Hemmer
Xin Zhang
Richa Shah
Verna L. Welch
Erik Vandendries
Matthias Stelljes
David I. Marks
Wael Saber
Show All
Source
Cite
Save
Citations (0)
Preliminary Exploration of Patient Perspectives on Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia
2019
Blood
Bradley Mason
Carla Mamolo
Chloe Johnson
Andrea Viqueira
Adam Gater
Alexander Russell-Smith
S. Tatlock
Richa Shah
Joseph C. Cappelleri
Show All
Source
Cite
Save
Citations (0)
Pharma Collaboration for Transparent Medical Information (phactMI) Benchmark Study: Trends, Drivers, Success Factors, and Value of Globalization in Medical Information
2018
Therapeutic Innovation & Regulatory Science
Suzana A. Giffin
Richa Shah
Allison Soloff
Anna Markel Vaysman
Jane Oreper
Andrew Gažo
Pooja Gandhi
Ina Shah
Thomas Malieckal
Daniel Boulos
Teresa Flowers
Carolle A. Stevens
Michael S. Rocco
Aarti S. Patel
Dominick Albano
Show All
Source
Cite
Save
Citations (4)
1